3-Methoxytyramine as an indicator of impulse-induced dopamine release in rat brain in vivo
- PMID: 958511
- DOI: 10.1007/BF00507343
3-Methoxytyramine as an indicator of impulse-induced dopamine release in rat brain in vivo
Abstract
3-Methoxtyramine and dopamine accumulated in vivo in rat brain after monoamine oxidase inhibition with pargyline HCl. A dose of 100 mg/kg i.p. appeared to inhibit monoamine oxidase completely and led to a linear accumulation of 3-methoxytyramine for the first 90 min. Axotomy of the ascending dopaminergic fiber tract by means of a complete transverse cerebral hemisection almost completely blocked 3-methoxytyramine formation provided that catecholamine synthesis was inhibited with H 44/68 (Methylester of alpha-methyl-p-tyrosine). The dopamine receptor agonist apomorphine, 0.5 mg/kg i.p., decreased, while the dopamine receptor antagonist haloperidol, 2 mg/kg i.p., accelerated 3-methoxytyramine formation. gamma-Butyrolactone, 750 mg/kg i.p., not only decreased 3-methoxytyramine formation per se but also effectively antagonized the haloperidol-induced increase in 3-methoxytyramine accumulation. 3-Methoxytyramine formation after inhibition of monoamine oxidase appears to be a reliable indicator of impulse-induced dopamine release and metabolism.
Similar articles
-
3-Methoxytyramine and normetanephrine as indicators of dopamine and noradrenaline release in mouse brain in vivo.J Neural Transm. 1981;50(2-4):165-78. doi: 10.1007/BF01249138. J Neural Transm. 1981. PMID: 7241115
-
Effect of (+) amphetamine on monoamine synthesis and metabolism after axotomy in rat forebrain.Naunyn Schmiedebergs Arch Pharmacol. 1976 Dec;296(1):25-30. doi: 10.1007/BF00498836. Naunyn Schmiedebergs Arch Pharmacol. 1976. PMID: 1087702
-
Interaction of haloperidol and gamma-butyrolactone with (+)-amphetamine-induced changes in monoamine synthesis and metabolism in rat brain.J Neural Transm. 1977;40(2):129-47. doi: 10.1007/BF01250564. J Neural Transm. 1977. PMID: 323421 Review.
-
Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.J Neurochem. 1989 Apr;52(4):1170-82. doi: 10.1111/j.1471-4159.1989.tb01863.x. J Neurochem. 1989. PMID: 2564423
-
Dopaminergic neurons - alteration in the sensitivity of tyrosine hydroxylase to inhibition by endovenous dopamine after cessation of impulse flow.Biochem Pharmacol. 1976 Mar 15;25(6):649-54. doi: 10.1016/0006-2952(76)90239-2. Biochem Pharmacol. 1976. PMID: 6034 Review. No abstract available.
Cited by
-
Different changes in striatal dopamine metabolism induced by nicotine in mice kept at different ambient temperatures. Evidence for partly separate metabolic routes of dopamine derived from separate compartmentations.Naunyn Schmiedebergs Arch Pharmacol. 1986 Dec;334(4):373-6. doi: 10.1007/BF00569372. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 3821929
-
Interactions of morphine with apomorphine: behavioural and biochemical studies.Naunyn Schmiedebergs Arch Pharmacol. 1986 Dec;334(4):452-7. doi: 10.1007/BF00569385. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 3821935
-
In vivo effects of the Ca2+-antagonist nimodipine on dopamine metabolism in mouse brain.J Neural Transm. 1986;66(3-4):171-87. doi: 10.1007/BF01260912. J Neural Transm. 1986. PMID: 2431107
-
(+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists.Naunyn Schmiedebergs Arch Pharmacol. 1986 Nov;334(3):234-45. doi: 10.1007/BF00508777. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 2880302
-
Effects of taurine, homotaurine and GABA on hypothalamic and striatal dopamine metabolism.Naunyn Schmiedebergs Arch Pharmacol. 1992 Jul;346(1):57-62. doi: 10.1007/BF00167571. Naunyn Schmiedebergs Arch Pharmacol. 1992. PMID: 1407006